Lung Cancer Clinical Trials

Showing 661-680 of 4,288 trials

Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer

NCT04966676

The purpose of this research study is to look at how effective two drugs, nivolumab and ipilimumab, are for people with non-small lung cancer that has metastasized (has spread to other parts of the body) and to see what effects these drugs have on these tumors.

Non Small Cell Lung Cancer

University Health Network, Toronto5 participantsStarted Jan 2022

Toronto, Ontario, Canada

RECRUITING

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

NCT07325864

investigate the molecular differences between primitive lung cancer and the metastatic site.

NSCLCLung Cancer (Diagnosis)

European Institute of Oncology25 participantsStarted Dec 2025

Milan, Italy

RECRUITINGNA

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

NCT07161310

The aim of this clinical study is to learn more about the effects of urolithin A (MitoPure®) on the immune system of cancer patients receiving immune checkpoint inhibitor-based therapies. Any effects will be compared with patients who take a placebo instead of urolithin A (MitoPure®).

Solid CancerNon-Small Cell Lung CancerMelanoma

Goethe University45 participantsStarted Jan 2026

Frankfurt, Germany

RECRUITINGPhase 2/3

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

NCT07213375

The aim is to conduct a randomized controlled trial (RCT) with a high dose arm (1mg/kg) vs a low dose (8mg in total) of steroid (Dexamethasone) given intravenous (IV) after the induction of anesthesia to "High-pain-responders" in patients undergoing VATS lobectomy/segmentectomy. The hypothesis is that a high dose of Dexamethasone can lower pain when coughing in the morning after VATS lobectomy/segmentectomy, in patients scoring as "High-pain-responders" on the Pain-Catastrophizing-Scale

AnalgeticLung Cancer (NSCLC)Video Assisted Thoracic Surgery (VATS)+1 more

Rigshospitalet, Denmark80 participantsStarted Sep 2025

Copenhagen, Copenhagen, Denmark

Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

Related Searches

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors

A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

C-TIL051 in Non-Small Cell Lung Cancer

Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients

The HER Project: HRD in EGFR-mutated NSCLC